Tetra Radar · FDA Approvals · Decision date

Unicycive Therapeutics, Inc.: FDA decision date

Unicycive Therapeutics, Inc. (UNCY) · 29 June 2026

In January 2026, the FDA accepted the resubmission of the NDA for OLC, deeming the resubmission to be a Class II complete response which has a six-month review period from the date of resubmission, and set a PDUFA target action date of June 29, 2026.

Source: 10-Q of 12 May 2026

The date has passed; Tetra Radar has not recorded an approval.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.